• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Product Classification

  • Print
  • Share
  • E-mail
-
New Search Back To Search Results
Device 21-hydroxylase antibody (21-ohab)
Regulation Description Multiple autoantibodies immunological test system.
Definition For semi-quantitative determination of antibodies to steroid 21-hydroxylase (21-oh) in human serum.The assay may be useful as an aid in the diagnosis of autoimmune adrenal disease, whether expressed as autoimmune addison's disease (isolated) or addison's disease as part of more complex autoimmune polyglandular syndrome (aps), type i or ii.The assay result is to be used in conjunction with other clinical and laboratory findings and is not a substitute for functional testing required to diagnose adrenal insufficiency.
Physical State RIA Assay Kit with reagents, antigen with I-125, calibrators, controls and assay buffer.
Technical Method RIA
Target Area None
Regulation Medical Specialty Immunology
Review Panel Immunology
Product CodePCG
Premarket Review Office of In Vitro Diagnostics and Radiological Health (OIR)
Submission Type 510(k)
Regulation Number 866.5660
Device Class 2
Total Product Life Cycle (TPLC) TPLC Product Code Report
GMP Exempt? No
Third Party Review Not Third Party Eligible
-
-